Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: Implications for synaptic dysfunction and neuronal damage

P (Hemachandra) Reddy

    Research output: Contribution to journalArticle

    49 Citations (Scopus)

    Abstract

    Glycogen synthase kinase 3 (GSK3) is a serine/threonine protein kinase that is involved in the multiple signaling processes of a cell. Increasing evidence suggests that GSK3β plays a key role in multiple cellular processes in the progression of diabetes, obesity, Alzheimer's disease (AD), Parkinson's disease (PD), inflammatory diseases, schizophrenia, bipolar and several mood disorders, and mitochondrial diseases. Recent research has found that increased GSK3β activity is linked to the pathogenesis of AD through amyloid beta (Aβ), phosphorylated tau and mitochondrial dysfunction. Recent research has also revealed that GSK3β is elevated in AD-affected tissues and is critically involved in dissociating the voltage-dependent anion channel 1 (VDAC1) protein from hexokinases, and causing disrupted glucose metabolism, mitochondrial dysfunction and activating apoptotic cell death. The purpose of this article is to review recent research that is elucidating the role of GSK3β in AD pathogenesis. We discuss the involvement of GSK3β in the phosphorylation of VDAC1 and dissociation of VADC1 with hexokinases in AD neurons.

    Original languageEnglish (US)
    Pages (from-to)1913-1921
    Number of pages9
    JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
    Volume1832
    Issue number12
    DOIs
    StatePublished - 2013

    Fingerprint

    Voltage-Dependent Anion Channel 1
    Glycogen Synthase Kinase 3
    Amyloid
    Alzheimer Disease
    Hexokinase
    Research
    Mitochondrial Diseases
    Protein-Serine-Threonine Kinases
    Mood Disorders
    Parkinson Disease
    Glycogen Synthase Kinase 3 beta
    Schizophrenia
    Cell Death
    Obesity
    Phosphorylation
    Neurons
    Glucose

    Keywords

    • Alzheimer's disease
    • Amyloid beta
    • Amyloid beta precursor protein
    • Glycogen synthase kinase 3beta
    • Mitochondria
    • Voltage-dependent anion channel 1

    ASJC Scopus subject areas

    • Molecular Biology
    • Molecular Medicine

    Cite this

    @article{aee898a8128b4b8c8735c09a2a4cafdd,
    title = "Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: Implications for synaptic dysfunction and neuronal damage",
    abstract = "Glycogen synthase kinase 3 (GSK3) is a serine/threonine protein kinase that is involved in the multiple signaling processes of a cell. Increasing evidence suggests that GSK3β plays a key role in multiple cellular processes in the progression of diabetes, obesity, Alzheimer's disease (AD), Parkinson's disease (PD), inflammatory diseases, schizophrenia, bipolar and several mood disorders, and mitochondrial diseases. Recent research has found that increased GSK3β activity is linked to the pathogenesis of AD through amyloid beta (Aβ), phosphorylated tau and mitochondrial dysfunction. Recent research has also revealed that GSK3β is elevated in AD-affected tissues and is critically involved in dissociating the voltage-dependent anion channel 1 (VDAC1) protein from hexokinases, and causing disrupted glucose metabolism, mitochondrial dysfunction and activating apoptotic cell death. The purpose of this article is to review recent research that is elucidating the role of GSK3β in AD pathogenesis. We discuss the involvement of GSK3β in the phosphorylation of VDAC1 and dissociation of VADC1 with hexokinases in AD neurons.",
    keywords = "Alzheimer's disease, Amyloid beta, Amyloid beta precursor protein, Glycogen synthase kinase 3beta, Mitochondria, Voltage-dependent anion channel 1",
    author = "Reddy, {P (Hemachandra)}",
    year = "2013",
    doi = "10.1016/j.bbadis.2013.06.012",
    language = "English (US)",
    volume = "1832",
    pages = "1913--1921",
    journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
    issn = "0925-4439",
    publisher = "Elsevier",
    number = "12",

    }

    TY - JOUR

    T1 - Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease

    T2 - Implications for synaptic dysfunction and neuronal damage

    AU - Reddy, P (Hemachandra)

    PY - 2013

    Y1 - 2013

    N2 - Glycogen synthase kinase 3 (GSK3) is a serine/threonine protein kinase that is involved in the multiple signaling processes of a cell. Increasing evidence suggests that GSK3β plays a key role in multiple cellular processes in the progression of diabetes, obesity, Alzheimer's disease (AD), Parkinson's disease (PD), inflammatory diseases, schizophrenia, bipolar and several mood disorders, and mitochondrial diseases. Recent research has found that increased GSK3β activity is linked to the pathogenesis of AD through amyloid beta (Aβ), phosphorylated tau and mitochondrial dysfunction. Recent research has also revealed that GSK3β is elevated in AD-affected tissues and is critically involved in dissociating the voltage-dependent anion channel 1 (VDAC1) protein from hexokinases, and causing disrupted glucose metabolism, mitochondrial dysfunction and activating apoptotic cell death. The purpose of this article is to review recent research that is elucidating the role of GSK3β in AD pathogenesis. We discuss the involvement of GSK3β in the phosphorylation of VDAC1 and dissociation of VADC1 with hexokinases in AD neurons.

    AB - Glycogen synthase kinase 3 (GSK3) is a serine/threonine protein kinase that is involved in the multiple signaling processes of a cell. Increasing evidence suggests that GSK3β plays a key role in multiple cellular processes in the progression of diabetes, obesity, Alzheimer's disease (AD), Parkinson's disease (PD), inflammatory diseases, schizophrenia, bipolar and several mood disorders, and mitochondrial diseases. Recent research has found that increased GSK3β activity is linked to the pathogenesis of AD through amyloid beta (Aβ), phosphorylated tau and mitochondrial dysfunction. Recent research has also revealed that GSK3β is elevated in AD-affected tissues and is critically involved in dissociating the voltage-dependent anion channel 1 (VDAC1) protein from hexokinases, and causing disrupted glucose metabolism, mitochondrial dysfunction and activating apoptotic cell death. The purpose of this article is to review recent research that is elucidating the role of GSK3β in AD pathogenesis. We discuss the involvement of GSK3β in the phosphorylation of VDAC1 and dissociation of VADC1 with hexokinases in AD neurons.

    KW - Alzheimer's disease

    KW - Amyloid beta

    KW - Amyloid beta precursor protein

    KW - Glycogen synthase kinase 3beta

    KW - Mitochondria

    KW - Voltage-dependent anion channel 1

    UR - http://www.scopus.com/inward/record.url?scp=84882738357&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84882738357&partnerID=8YFLogxK

    U2 - 10.1016/j.bbadis.2013.06.012

    DO - 10.1016/j.bbadis.2013.06.012

    M3 - Article

    C2 - 23816568

    AN - SCOPUS:84882738357

    VL - 1832

    SP - 1913

    EP - 1921

    JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

    JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

    SN - 0925-4439

    IS - 12

    ER -